When the Federal Trade Commission goes before the Supreme Court in March to argue against brand-generic patent settlements involving generic compensation, it will have a new figure to tout. In fiscal year 2012 there were 40 potential “pay-for-delay” deals, a 42.8% increase from the previous year’s tally of 28.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?